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Cover letter AJD-D-12-00022 R1 
 
Dear Dr. Sangüeza, dear Omar 
 
Enclosed please find the revised manuscript  " Primary cutaneous CD8+ small to medium-
sized lymphoproliferative disorder in extrafacial sites - clinicopathological features and 
concepts on their classification" (AJD-D-12-00022). We are very grateful for your comments 
and the comments of the reviewers. Enclosed please find the point-by-point answers to their 
comments. The corresponding changes in the manuscript has been highlighted in red.  
 
We hope that the revised manuscripts fulfills the requirements and very high standard for 
publication in the Journal. We very much appreciate your evaluation of our manuscript. 
 
Yours sincerely, 
 
Werner  
 
 
Point-by-point answers to the reviewer's comments 
Reviewer #1:  
 
Reviewer #1: An excellent paper on an evolving topic. As more cases like these emerge, we 
will be able to say with more confidence where this entity lies along the PTCL, NOS 
spectrum. 
 
1. Interesting that only one of three cases showed +clonality. the multiplicity of the lesions in 
case 1 suggests lymphoma as does dim cd3 in case 3 (i think cd3 is present but dim).  
Reply: In fact a clonal T-cell population was found in two one of the three cases (Cases 2 
and 3 - repeating the clonality assay in the biopsy of patient 3 revealed also clonal T-cells). 
This detection rate of clonality is very similar to the one in the CD4+ small/medium-sized T-
cell lymphoma, which represents a form of analogon to our CD8+ cases (Beltraminelli et al. 
Am J Dermatopathol 2009). Moreover we agree with the reviewer that the occurrence of 
multiple and recurrent lesions, which only partially responded to radiotherapy and 
methotrexate, in Case 1 prove the diagnosis of a lymphoma.  
 
2. Would have been very interesting to do ebv on case 3, especially with presence of 
numerous b cells. bcells in PTCL has been linked to ebv expression (mattoch et al., ajcp, 
2009). these lymphomas are thought to represent secondary cutaneous disease but looks 
like in case 3, the course is indolent. i assume staging work up was negative? 
Reply: We are grateful for this comment. We have performed in situ hybridization for EBV 
transcripts (EBER) and PCR for EBV DNA, which both were negative. The staging 
examinations were negative. This informations were added to th erevised manuscript in the 
section "Results".  
 
3.I think in cases with documented small populations of cd4+ cells, that those may be 
background reactive cells. they may be small and angulated like the tumor cells. 
Reply: We fully agree with the interpretation that the CD4+ T-cells represent background 
reactive cells.  
 
4. Very interesting that lesional cells express granzyme but not tia1==may also be indicative 
of lymphoma. 
Reply: We also interpret this finding as a further argument in favor of a lymphoma.  
 
5. The manuscript should be proofed by a native english speaker. the figure legends should 
be expanded to include complete descriptive sentences about the figures. figures are very 
nice. 
Cover Letter R1
Reply: The manuscrript has been proofed by Dr. Walter Burgdorf, MD, who is a native 
English speaker and editor of several dermatology and dermatopathology books. Complete 
descriptive sentences were added to the figure legends.  
 
Comment by the authors: 
In addition, we have slightly changed the title and use the term "lymphoproliferative disorder" 
instead of "lymphoproliferation" since the first term is more consistent with the terminology 
used in current lymphoma classifications.  
Abstract 
Three cases with CD8+ small to medium-sized lymphoproliferations in the skin at extrafacial 
sites are described. Clinically, the patients presented with papulo-nodular or plaque-like 
lesions without preceding patches. Histopathologically, non-epidermotropic nodular or diffuse 
infiltrates were composed of small to medium-sized pleomorphic lymphocytes which 
expressed CD8 (more than 80% of the cells) and granzyme B (60-70% of the cells), but were 
negative for CD4, CD30 and CD56. There was no association with Epstein-Barr virus. A 
clonal T-cell population was detected in two patients. Staging examinations did not reveal 
extracutaneous involvement. The two patients with solitary lesions underwent complete 
remission after radiation therapy, whereas one patient developed multifocal lesions and 
several recurrences. These CD8+ small to medium-sized lymphoproliferations of the skin at 
extrafacial sites may belong to a spectrum of a phenotypically and prognostically 
heterogeneous cutaneous small to medium-sized lymphoid proliferations which are 
characterized by an indolent course in most patients. 
 
Abstract R1
1 
 
Primary cutaneous CD8+ small to medium-sized lymphoproliferative disorder in 
extrafacial sites - clinicopathological features and concepts on their classification 
 
Authors: Werner Kempf, MD (1, 2), Dmitry V. Kazakov, MD, PhD (3), Antonio Cozzio,  
  MD, PhD (2), Jivko Kamarashev (2), Katrin Kerl, MD, (2), Tobias Plaza, MD (4), 
  Dieter Metze, MD (5) 
Institutions: 
(1) Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland 
(2) Department of Dermatology, University Hospital, Zürich, Switzerland, 
(3)  Sikl's Department of Pathology, Charles University, Medical Faculty Hospital, Pilsen, 
Czech Republic  
(4) Dermatology Practice, Uster, Switzerland 
(5) Departments of Dermatology, University Hospital Münster, Münster, Germany.  
 
Emails: werner.kempf@access.uzh.ch; Dmitry Kazakov <kazakov@medima.cz>; Cozzio 
Antonio <Cozzio@usz.ch>; Kerl Katrin <katrin.kerl@usz.ch>; Kamarachev Jivko 
<jivko.kamarachev@usz.ch>; Tobias Plaza <tobias.plaza@gmx.ch>; metzed@uni-muenster.de 
 
Running title:  Extrafacial CD8+ lymphoid proliferation 
 
Key words:  CD8, extrafacial, lymphoproliferative, small to medium-sized, lymphoma,  
   pseudolymphoma 
 
Corresponding author:  
Werner Kempf, MD 
Kempf und Pfaltz Histologische Diagnostik 
CH-8042, Zürich, Switzerland  
Tel +41-44-2333377 
Fax +41-44-2333378 
E-mail: werner.kempf@access.uzh.ch 
*Manuscript R1 new
2 
 
Abstract 
Three cases with CD8+ small to medium-sized lymphoproliferations in the skin at extrafacial 
sites are described. Clinically, the patients presented with papulo-nodular or plaque-like lesions 
without preceding patches. Histopathologically, non-epidermotropic nodular or diffuse infiltrates 
were composed of small to medium-sized pleomorphic lymphocytes which expressed CD8 
(more than 80% of the cells) and granzyme B (60-70% of the cells), but were negative for CD4, 
CD30 and CD56. There was no association with Epstein-Barr virus. A clonal T-cell population 
was detected in two patients. Staging examinations did not reveal extracutaneous involvement. 
The two patients with solitary lesions underwent complete remission after radiation therapy, 
whereas one patient developed multifocal lesions and several recurrences. These CD8+ small to 
medium-sized lymphoproliferations of the skin at extrafacial sites may belong to a spectrum of a 
phenotypically and prognostically heterogeneous cutaneous small to medium-sized lymphoid 
proliferations which are characterized by an indolent course in most patients. 
 
 
Key words cutaneous small to medium-sized pleomorphic T-cell lymphoma, primary cutaneous 
aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma, cutaneous peripheral T-cell 
lymphoma not otherwise specified, cytotoxic lymphoma, indolent CD8-positive lymphoid 
proliferation of the ear, pseudolymphoma 
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Introduction 
In the recent literature, there have been several reports of unusual proliferations of CD8+ 
lymphocytes of the skin which posed diagnostic problems, especially with regard to their 
classification according to the currently used schemes, and particularly the WHO/EORTC 
classification of cutaneous lymphomas. (1), (2), (3), (4) Those cases clearly differed from 
primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (CTCL), as well 
as from other lymphoma types with CD8 expression such as subcutaneous panniculitis-like T-
cell lymphoma, and lymphomas with occasional expression of CD8 such as mycosis fungoides, 
cutaneous gamma/delta T-cell lymphoma, and extranodal NK/T-cell lymphoma, nasal type (5), 
(6), (7), (8) Cases in which the lesions were located on the face, often involving the ear have 
been referred to as “indolent CD8-positive lymphoid proliferation of the ear and face“, 
respectively are characterized by nodular infiltrates of small to medium-sized CD8-positive 
lymphocytes. Only two patients with a nodular infiltrate of CD8+ small to medium-sized 
lymphocytes have been reported in extrafacial locations. (9), (10) A common clinical feature of 
the reported cases of CD8+ small to medium-sized lymphoid infiltrates was an indolent course, 
which is in contrast to a rare subset of peripheral CTCL, not otherwise specified (NOS) with a 
cytotoxic phenotype which usually follows an aggressive course. (11) Some authors feel that the 
infiltrates of CD8+ small to medium-sized lymphocytes cases are morphologically related to 
primary cutaneous small to medium-sized pleomorphic T-cell lymphoma (SMPTL) except for 
the fact that the small to medium-sized lymphocytes in SMPTL express CD4 (1), (2), (3), (4) 
Here we present the clinicopathological features of three cases of extrafacial proliferations of 
small to medium-sized CD8+ lymphocytes of the skin and discuss their possible categorization.  
 
Material and Methods  
A total of 6 biopsies from 3 patients were available for a histopathological review. Biopsy 
specimens were fixed in 10% buffered formalin and sections were routinely processed and 
embedded in paraffin. Serial 4 micrometer-thick sections were cut for hematoxylin and eosin 
stains as well as immunohistochemical stains. The antibodies used for immunohistochemistry 
included: CD2 (1:50, Novocastra/Leica-Microsystems, Heerbrugg, Switzerland), CD3 (1:75, 
Dako, Glostrup, Denmark), CD4 (1:2, Novocastra/Leica-Microsystems, Heerbrugg, 
Switzerland), CD7 (1:25, Dako, Glostrup, Denmark), CD8 (1:400, Dako, Glostrup, Denmark), 
CD20 (1:600, Dako, Glostrup, Denmark), CD30 (1:75; Novocastra/Leica-Microsystems, 
Heerbrugg, Switzerland), CD56 (RTU, Novocastra/Leica-Microsystems, Heerbrugg, 
Switzerland), and TIA-1 (1:50, Immunotech Marseille, France), as well as granzyme B (1:50; 
Dako, Glostrup, Denmark) and perforin (1:20; Novocastra/Leica-Microsystems, Heerbrugg, 
Switzerland), beta F1 (1:50, Thermo Scientific, Germany).  Immunostaining was performed 
according to standard protocols using alkaline phosphatase-anti-alkaline phosphatase method, 
avidin-biotin complex or streptavidin-biotin complex labeled with peroxidase or alkaline 
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phosphatase. Appropriate positive and negative controls were applied. The antibody panel used 
differed in individual cases depending on the availability of the tissue/antibodies. 
 
In all cases, molecular T-cell receptor (TCR) rearrangement studies were performed using a 
multiplex polymerase chain reaction (PCR) as described elsewhere. (12) Appropriate positive 
and negative controls were included in all analyses. Also, in situ hybridization for EBV was 
performed.   
 
Results 
Clinical data 
Case 1. A 48-year-old man presented in June 2007 with an erythematous nodule (diameter 1cm) 
on the right buttock. He had Bruton X-linked agammaglobulinemia that had been treated with 
immunoglobulin substitution for the previous 21 years. The lesion was excised. Three years later 
in April 201, he developed infiltrated tan plaques on the dorsal aspects of the left foot and toes 
(Figure 1A). The working histopathologic diagnosis was ”suspicious for cytotoxic lymphoma”, 
so the patient was investigated to exclude extracutaneous disease (including peripheral blood 
studies and PET-CT), but no extracutaneous involvement was found. In May 2010 the lesions 
were treated with radiation therapy (total dose 32 Gy using 100kV) with complete regression. In 
March 2011 a relapse with a plaques on the left foot was observed (Figure 1B) which was treated 
again with radiation therapy (total dose 52 Gy using 40kV; March to June 2011) which again 
resulted in complete regression. Three months later, the patient developed the second recurrence 
of small livid papules on the left foot adjacent to the radiation site and in addition 3 small 
papulo-nodular lesions (diameter up to 8mm) in the right retroauricular area. The staging 
examinations (peripheral blood studies, PET/CT) were repeated and were once again negative. In 
parallel to the superficial X-ray irradiation for the retroauricular lesions, treatment with low-dose 
methotrexate (15mg/week) was started in November 2011 and resulted in complete remission 
until last follow-up in January 2012. Several biopsies of the lesions on the right buttock, the 
lesions on the feet and the retroauricular papulo-nodular lesions were histologically examined.  
Case 2. An 87-year-old woman presented with a solitary, red infiltrated non-scaling plaque 
(diameter 5 cm) on the right lower leg (Figure 2). Her medical history was unremarkable for skin 
or neoplastic diseases. The clinical examination did not reveal enlarged lymph nodes. The lesion 
was treated by radiation therapy (total dose 50 Gy). No recurrence was observed during follow-
up of 2 years.  
Case 3. A 52-year-old man presented with a 1.3x0.8 cm solitary nodule on the right shoulder. 
The lesion was completely excised. The staging examinations did not reveal any extracutaneous 
involvement. One year later, there was no evidence of cutaneous and extracutaneous disease. 
Blood examinations revealed a mild lymphocytosis, but no atypical lymphocytes. All findings 
were normal at the last follow-up 26 months after diagnosis. 
Histopathologic, immunophenotypic and molecular findings 
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Common to all cases was a dense nodular to diffuse dermal infiltrate composed mainly of small 
and medium-sized lymphocytes were found which were separated from the overlying epidermis 
by a variably thick Grenz zone (Figures 1C, 3A and 3B). The epidermis was either normal or 
focally atrophic with a loss of the undulated pattern. Specifically, no epidermotropism was 
observed in any of the biopsies of all three patients (Figure 3B). In all biopsies, the small to 
medium-sized lymphocytes showed chromatin dense nuclei with mild to moderate nuclear 
pleomorphism with cleaved nuclei (Figures 1D and 3C). A few eosinophilic granulocytes were 
admixed. In patient 1, several biopsies showed a granulomatous component with numerous 
histiocytes occasionally forming small epithelioid granulomas in addition to the lymphocytic 
infiltrate (Figure 1E). In addition, the lymphocytic infiltrates were centered on a slightly 
hyperplastic hair follicle but there was no folliculotropism in one of the biopsies of the acral 
lesions in patient 1 (Figure 1C).  
Immunohistochemically, the small to medium-sized lymphocytes were strongly positive for 
CD8, with about 80-90% of the cell population staining for this marker in each specimen 
(Figures 1F, 3D and 3E) (Table 1). A minority of the small lymphocytes (10-30% of the cells) 
expressed CD4 (Figures 1G and 3F). The cells expressed other T-cell markers (CD2, CD3 
[except for patient 3], CD5 and CD7) and were positive for betaF1 (Figure 3G). The CD8+ 
lymphocytes were negative for TIA-1, but granzyme B was expressed by 60-70% of the small to 
medium-sized lymphocytes in the biopsies of patient 1 and 2. In the biopsies of all patients, the 
lymphocytes were consistently negative for CD30 and CD56. There was an admixture of 
scattered medium-sized B-cells in the biopsy of patient 3. Less than 10 percent of the small to 
medium-sized CD8+ lymphocytes displayed proliferative activity in the Ki67/MIB-1 staining 
(Figure 1H). In the two patients (patients 1 and 3), from whom multiple biopsied were studied, 
the immunoprofile of the lymphoid cells was identical in each specimen. In situ hybridization for 
EBV RNA (EBER) performed in biopsies of all patients were negative.  
Molecular biological T-cell clonality analyses revealed a clonal T-cell population in the biopsy 
of patient 2 and patient 3, whereas the infiltrates in the patient 1 were polyclonal (Table 1).  
Discussion 
The common clinicopathological features to all our cases are papulo-nodular or plaque-like 
lesions without preceding patches and histologically nodular proliferations of small to medium-
sized CD8+ lymphocytes lacking epidermotropism. In the context of cutaneous lymphoid 
infiltrates, cases showing a cytotoxic phenotype should always alert the pathologist to a 
possibility of an aggressive cutaneous lymphoma but the lesions in our three patients are clearly 
different, both clinically and histopathologically, from aggressive cytotoxic lymphomas such as 
primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma and other aggressive 
lymphoma type in which CD8 expression is commonly or occasionally observed such as 
subcutaneous panniculitis-like T-cell lymphoma, cutaneous gamma/delta T-cell lymphoma, and 
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extranodal NK/T-cell lymphoma, nasal type. (13), (14), (15) CD8 phenotype has rarely been 
observed in less aggressive or rather indolent CTCL including mycosis fungoides, pagetoid 
reticulosis and CD30+ anaplastic large cell lymphoma. (16), (17), (18), (19) A cytotoxic 
infiltrate has recently been found in peculiar form of lupus erythematosus which showed 
overlapping clinicopathological features of subcutaneous panniculitis-like T-cell lymphoma and 
lupus erythematosus. (20) All of the above diagnoses were clearly excluded in our patients. In 
particular, the lack of epidermotropism in all biopsies and the absence of preceding patches 
argue against CD8+ variant of MF as well as primary cutaneous aggressive epidermotropic 
CD8+ T-cell lymphoma. Cutaneous gamma/delta lymphoma is excluded by the presence of beta 
F1 expression. The indolent clinical course and the lack of association with EBV exclude 
extranodal NK/T-cell lymphoma.  
 
Histopathologically, our cases are very similar to those reported as indolent CD8+ lymphoid 
proliferation of the ear (or face) but in all of our patients the lesions were located in extrafacial 
sites. So far, 5 patients (including our 3 patients) with CD8+ small/medium-sized lymphoid 
infiltrates at extrafacial sites have been reported (9), (10)  Their clinicopathologic features are 
summarized in Table 1. Clinically and histologically our cases are very similar or even identical 
to the patient reported by Khamaysi et al which was interpreted by the authors as CD8+ small to 
medium-sized pleomorphic CTCL. (10) Classification of the CD8+ lymphoid infiltrates in our 
cases is challenging. Although the term cutaneous peripheral T-cell lymphoma, NOS (PTL, 
NOS) can be applied to cases which do not fit into any of the well-defined forms of CTCL and 
CD8 phenotype has indeed been observed in peripheral T-cell lymphoma, NOS, including cases 
with small to medium-sized cytomorphology, such tumors usually run an aggressive clinical 
course. In a large study, cytotoxic phenotype was found in about 15% of peripheral T-cell 
lymphoma, NOS, and a median survival of the affected patients was 28 months. (11) Clinically, 
our cases show a similar biological behavior as seen in CD4+ SMPTL which manifests in the 
vast majority of the patients with solitary or grouped plaques or nodules and runs an indolent 
course with an excellent prognosis (11), (21). Therefore our cases could be regarded as a 
phenotypic CD8+ lymphoproliferative analogue to the CD4+ SMPTL (Figure 4). The presence 
of small and medium-sized lymphocytes with nuclear atypia, the detection of clonal T-cells in 
two of three cases and the relapses in one of the patients are in favor of a lymphoma. 
 
In regard to the indolent course and the overlapping histological features, some authors have 
indicated that CD4+ SMPTL cannot be distinguished with certainty form nodular pseudo-T-cell 
lymphoma and therefore proposed the term "cutaneous nodular proliferation of pleomorphic T-
lymphocytes of undetermined significance (21), (22). In fact, some cases of pseudolymphoma 
composed of small and occasional medium-sized cells may be overdiagnosed at present as small 
to medium-sized pleomorphic T-cell lymphoma. (21), (23) Moreover, a CD8 phenotype has been 
reported in rare cutaneous pseudolymphomas in HIV-positive patients and other conditions 
characterized by lymphoid infiltrates, including lymphoid infiltration of Jessner-Kanof and 
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palpable arciform migratory erythema (24), (25), (26) These lesions feature a less prominent 
infiltrate composed almost exclusively of small cells. The possibility that the infiltrate in our 
patient 3 represents a form of pseudolymphoma (reactive lymphoid hyperplasia) cannot be 
totally refuted. The history did not indicate a drug-related form of pseudolymphoma as no 
association with drug intake had been reported by the patient. In addition, the lack of CD3 
expression by the small to medium-sized tumor cells in case 3 argues against pseudolymphoma.  
 
Patients with SMPTL appear to have a favorable prognosis independent of their CD4 or CD8 -
positive phenotype, especially those with a solitary lesion (10), (27), (9), (23)  Nevertheless, the 
relapsing course and the multifocal occurrence of tumors in patient 1 may indicate that the 
extrafacial CD8+ lymphoid proliferations are a prognostically heterogenous group, as the same 
course also been reported in CD4+ SMPTL. In the latter entity, cases with multiple rapidly 
growing tumors and a high proliferation rate may run a more aggressive course. (28) Thus a 
patient with multiple lesions should be followed more intensively and may require more intense 
treatment.  
 
A surprising feature observed in one case (Case 1) was the conspicuous granulomatous 
infiltration in the first biopsy. In the context of cutaneous lymphomas, granulomatous features 
are typically present in granulomatous slack skin and granulomatous mycosis fungoides and are 
rare in other lymphoma types. (29), (30), (31), (32) They have also been described in 
pseudolymphomatous folliculitis, a term used to describe a distinctive pattern seen in both 
lymphomas and pseudolymphomas. (33), (34)  Along this line, some cases of 
“pseudolymphomatous folliculitis” and small to medium-sized pleomorphic CTCL show a great 
clinicopathological overlap. (34), (35), (36)  In our patient with Bruton X-linked  
agammaglobulinemia,  the granulomatous (and lymphomatous) infiltrate may be related to 
immunodeficiency or immunoglobulin substitution. Similar histopathological findings have 
recently been reported in a Japanese patient with X-linked agammaglobulinemia, including a 
heavy small to medium-sized non-epidermotropic lymphoid infiltrate with cytotoxic CD8+ 
phenotype and a great admixture of histiocytes. (37)  The tumor was classified as peripheral 
CTCL, NOS and the patient clinically presented with multiple papules, macules and patches on 
the face and trunk. (37)  
 
In conclusion, we report a series of CD8+ small to medium-sized cell lymphoid proliferations of 
the skin with an indolent behavior similar to those reported for CD8+ lymphoid proliferation on 
the ear and face, but all occurring in extrafacial sites. Further observations are needed collect a 
larger number of such cases in order to get insight into the biologic nature of the lesion -
lymphoma or reactive process-and to find out whether they represent a prognostically 
heterogeneous group of lesions. If such lymphoid proliferations should be classified as 
lymphoma, then according to the currently used schemes (WHO classification, 2008, 4th edition) 
they would conform to the concept of cutaneous PTL, NOS and could perhaps be regarded as the 
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CD8+ analogue of CD4+ SMPTL within a larger spectrum of nodular infiltrates of small to 
medium-sized pleomorphic lymphocytes (Figure 4). We propose the term primary cutaneous 
CD8+ small to medium-sized lymphoproliferative disorder. A growing body of evidence 
suggests that what is now called small to medium-sized pleomorphic CTCL may in fact represent 
a phenotypically and prognostically heterogeneous group of lymphoid proliferations. (28)  
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Figures 
 
Figure 1: Patient 1 - Clinicopathologic findings 
Fig. 1A: A scaly brownish plaque on the left foot was present at initial presentation. 
Fig. 1B: Relapse with erythematous papules developed adjacent to the site of previous radiation 
therapy.  
Fig. 1C: Superficial and deep nodular and confluent infiltrates were present in all dermal layers. 
H&E, original magnification X20  
Fig. 1D: The infiltrates consisted of small to medium-sized pleomorphic lymphocytes with 
chromatin dense nuclei, H&E, original magnification X400 
Fig. 1E: There is a granulomatous component with sarcoid-like granulomas and numerous small 
to medium-sized lymphocytes with nuclear atypia. H&E, original magnification X200, 
Fig 1F: CD8 (red) is expressed by more than 80% of the small to medium-sized lymphocytes. 
Immunohistochemistry, original magnification X200. 
Fig 1G: Only small lymphocytes accounting for less than 20% of the infiltrate express CD4. 
(red). Immunohistochemistry, original magnification X200. 
Fig 1H: Proliferative activity is found in less than 10% of small to medium-sized pleomorphic 
lymphocytes.  
 
Figure 2: Patient 2 - Erythematous plaque on the right lower leg 
 
Figure 3: Patient 3 - Histological and phenotypic findings 
Fig 3A: Superficial and deep nodular infiltrates were found in all dermal layers. H&E, original 
magnification X20 
Fig. 3B: The lymphocytic infiltrates were separated from the overlying epidermis by an 
infiltrate-free Grenz zone. H&E, original magnification X200 
Fig. 3C: The infiltrates consisted of small to medium-sized pleomorphic lymphocytes, H&E, 
original magnification X400 
Fig. 3D: CD8 (red) is expressed by nearly all lymphocytes. Immunohistochemistry, original 
magnification X100. 
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Fig. 3E: CD8 (red) is expressed by more than 80% of the small to medium-sized pleomorphic 
lymphocytes. Immunohistochemistry, original magnification X200. 
Fig. 3F: Expression of CD4 (red) is found by less than 10% of the small to medium-sized 
pleomorphic lymphocytes. Immunohistochemistry, original magnification X200. 
Fig 3G: Less than 25% of the small to medium-sized pleomorphic lymphocytes express CD3 
(red). Immunohistochemistry, original magnification X200. 
 
Figure 4: Concept on the relationship between primary cutaneous small to medium-sized T-cell 
lymphoma with CD4+ or CD8+ expression, cutaneous CD8+ lymphoid proliferation of 
the ear / face and nodular pseudo-T-cell-lymphoma.  
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Table 1. The main clinicopathological features of cutaneous CD8+ small to medium-sized 
lymphoid proliferations in extrafacial sites 
 
Case Sex/Age Location Clinical 
features 
Treatment 
Follow-up 
Histology IHC TCR 
Case 1 
 
M/48 Buttock 
(2007) 
Lower leg 
(2010) 
Multiple 
infiltrative 
papules and 
plaques 
Radiation 
therapy, 
 
Methotrexate 
(low-dose) 
 
Alive with 
disease (FU: 48 
months) 
Nodular 
infiltrate 
Small to 
medium-sized 
cells; no 
epidermotropis
m 
Granulomatous 
reaction in one 
specimen 
CD2+, CD3+, 
CD4 (30%), 
CD5+,CD8 
(80%), CD30-, 
CD56-, 
granzyme 
(70%), 
perforin -TIA1 
(890%) 
Negative 
Case 2 
 
F/87 Lower leg Red 
infiltrated 
plaque 
Radiation therapy 
 
Complete  
remission 
(FU: 24 months) 
Diffuse infiltrate 
Small to 
medium-sized 
cells; no 
epidermotropis
m 
CD2+, CD3+, 
CD4 (30%), 
CD5+, CD7+ 
CD8 (80%), 
CD30-, CD56-
, granzyme B 
(60%), 
perforin -, 
TIA1 (70%)-  
Positive 
Case 3 
 
M/54 Shoulder 1.3x0.8 cm 
solitary 
nodule 
Surgical excision 
 
 
Complete 
remission (FU: 
28 months) 
Nodular 
infiltrate  
Small to 
medium-sized 
cells; no 
epidermotropis
m 
CD3-, CD4 
(10%), CD5+, 
CD8 (90%), 
CD30-, CD56- 
Positive 
Case 
reported 
by  
Khamays
i et al 
2006 
F/55 Right foot Erythematou
s nodule 
(diameter 
2cm) 
Radiation therapy 
and surgical 
excision 
No FU available 
Lichenoid 
infiltrate 
Small to 
medium-sized 
cells; no 
epidermotropis
m 
CD3+, CD8+  
CD4- CD20. 
CD30-, CD56- 
Positive 
Case 
reported 
by 
Friedman
n et al. 
1995 
F/57 Widesprea
d lesions 
Tumors and 
nodules 
Mechlorethamine
, radiation 
therapy, 
Psoralen-UVA 
(PUVA), 
Interferon-alpha 
(FU: no evidence 
of disease at 86 
months)  
Small to 
medium-sized 
cells; no 
epidermotropis
m 
CD3+ ,CD8+ 
(50-75%) 
CD4 (<25%) 
CD5+, CD7- 
CD30- 
CD20 (<25%) 
 
Positive 
Legend: FU: Follow-up; ND: not done; NR: not reported 
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Abstract 
Three cases of CD8+ small to medium-sized lymphoproliferations of the skin at extrafacial sites 
are described. Clinically, the patients presented with papulo-nodular or plaque-like lesions 
without preceding patches. Histopathologically, non-epidermotropic nodular or diffuse infiltrates 
were composed of small to medium sized pleomorphic lymphocytes which expressed CD8 (more 
than 80% of the cells) and granzyme B (60-70% of the cells), but were negative for CD4, CD30 
and CD56. There was no association with Epstein-Barr virus. A clonal T-cell population was 
detected in one patient. Staging examinations did not reveal extracutaneous involvement. The 
two patients with solitary lesions underwent complete remission after radiation therapy, whereas 
one patient developed multifocal lesions and several recurrences. The CD8+ small to medium-
sized lymphoproliferations of the skin at extrafacial sites may belong to a spectrum of a 
phenotypically and prognostically heterogeneous cutaneous small to medium-sized lymphoid 
proliferations which are characterized by an indolent course in most patients. 
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Abstract 
Three cases of CD8+ small to medium-sized lymphoproliferations of the skin at extrafacial sites 
are described. Clinically, the patients presented with papulo-nodular or plaque-like lesions 
without preceding patches. Histopathologically, non-epidermotropic nodular or diffuse infiltrates 
were composed of small to medium sized pleomorphic lymphocytes which expressed CD8 (more 
than 80% of the cells) and granzyme B (60-70% of the cells), but were negative for CD4, CD30 
and CD56. There was no association with Epstein-Barr virus. A clonal T-cell population was 
detected in one patient. Staging examinations did not reveal extracutaneous involvement. The 
two patients with solitary lesions underwent complete remission after radiation therapy, whereas 
one patient developed multifocal lesions and several recurrences. The CD8+ small to medium-
sized lymphoproliferations of the skin at extrafacial sites may belong to a spectrum of a 
phenotypically and prognostically heterogeneous cutaneous small to medium-sized lymphoid 
proliferations which are characterized by an indolent course in most patients. 
 
  
Key words cutaneous small to medium-sized pleomorphic T-cell lymphoma, primary cutaneous 
aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma, cutaneous peripheral T-cell 
lymphoma not otherwise specified, cytotoxic lymphoma, indolent CD8-positive lymphoid 
proliferation of the ear, pseudolymphoma 
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Introduction 
In the recent literature, there have been several reports of unusual CD8+ lymphoid proliferations 
of the skin which posed diagnostic problems, especially with regard to their classification 
according to the currently used schemes, and particularly the WHO/EORTC classification of 
cutaneous lymphomas. (1), (2), (3), (4) Those cases clearly differed from primary cutaneous 
aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (CTCL), as well as from other 
lymphoma type with CD8 expression such as subcutaneous panniculitis-like T-cell lymphoma, 
and lymphomas with occasional expression of CD8 such as mycosis fungoides, cutaneous 
gamma/delta T-cell lymphoma, and extranodal NK/T-cell lymphoma, nasal type (5), (6), (7), (8) 
Cases in which the lesions were located on the face, often involving the ear have been referred to 
as “indolent CD8-positive lymphoid proliferation of the ear and face“, respectively are 
characterized by nodular infiltrates of small to medium-sized CD8-positive lymphocytes. So far 
only 2 patients with a nodular infiltrate of CD8+ small to medium-sized lymphocytes has been 
reported in acral, i.e. extrafacial location. (9), (10) A common clinical feature of the reported 
cases of CD8+ small to medium-sized lymphoid infiltrates was an indolent course, which is in 
contrast to a rare subset of peripheral CTCL, not otherwise specified (NOS) with a cytotoxic 
phenotype which usually follows an aggressive course. (11) Some authors felt that the infiltrates 
of CD8+ small to medium-sized lymphocytes cases are morphologically related to primary 
cutaneous small to medium-sized pleomorphic T-cell lymphoma (SMPTL) except for the fact 
that the small to medium-sized lymphocytes in SMPTL express CD4 (1), (2), (3), (4) Here we 
present the clinicopathological features of three cases of extrafacial small to medium sized CD8+ 
lymphoproliferations of the skin and discuss their possible categorization.  
 
Material and Methods  
A total of 6 biopsies from 3 patients were available for a histopathological review. Biopsy 
specimens were fixed in 10% buffered formalin and sections were routinely processed and 
embedded in paraffin. Serial 4 micrometer-thick sections were cut for hematoxylin and eosin 
stains as well as immunohistochemical stains. The antibodies used for immunohistochemistry 
included: CD2 (1:50, Novocastra/Leica-Microsystems, Heerbrugg, Switzerland), CD3 (1:75, 
Dako, Glostrup, Denmark), CD4 (1:2, Novocastra/Leica-Microsystems, Heerbrugg, 
Switzerland), CD7 (1:25, Dako, Glostrup, Denmark), CD8 (1:400, Dako, Glostrup, Denmark), 
CD20 (1:600, Dako, Glostrup, Denmark), CD30 (1:75; Novocastra/Leica-Microsystems, 
Heerbrugg, Switzerland), CD56 (RTU, Novocastra/Leica-Microsystems, Heerbrugg, 
Switzerland), and TIA-1 (1:50, Immunotech Marseille, France), as well as granzyme B (1:50; 
Dako, Glostrup, Denmark) and perforin (1:20; Novocastra/Leica-Microsystems, Heerbrugg, 
Switzerland), beta F1 (1:50, Thermo Scientific, Germany).  Immunostaining was performed 
according to standard protocols using alkaline phosphatase-anti-alkaline phosphatase method, 
avidin-biotin complex or streptavidin-biotin complex labeled with peroxidase or alkaline 
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phosphatase. Appropriate positive and negative controls were applied. The antibody panel used 
differed in individual cases depending on the availability of the tissue/antibodies. 
 
In all cases, molecular T-cell receptor (TCR) rearrangement studies were performed using a 
multiplex polymerase chain reaction (PCR) as described elsewhere. (12) Appropriate positive 
and negative controls were included in all analyses. Also, in situ hybridization for EBV was 
performed.   
 
Results 
Clinical data 
Case 1. A 48-year old man presented in June 2007 with an erythematous nodule (diameter 1cm) 
on the right buttock. The patient’s history was significant for Bruton’s X-linked 
agammaglobulinemia that had been treated with immunoglobulin substitution for the previous 21 
years. The lesion was excised. Three years later (April 2010) the patient developed infiltrated 
slightly brownish plaques on the dorsal aspects of the left foot and toes (Figure 1A). Following 
histopathological diagnosis with a suspicion for cytotoxic lymphoma the patient was clinically 
investigated to exclude extracutaneous disease (including PET-CT, peripheral blood 
investigation), but no extracutaneous involvement was found. In May 2010 the lesions were 
treated with radiation therapy (total dose 32 Gy using 100kV) with complete regression. In 
March 2011 a relapse with a plaques on the left foot was observed (Figure 1B) which was treated 
by radiation therapy (total dose 52 Gy using 40kV; March to June 2011) which again resulted in 
complete regression of the lesions. Three months later, the patient developed the second 
recurrence of small livid papules on the left foot adjacent to the radiation site and in addition 3 
small papulo-nodular lesions (diameter up to 8mm) in the right retroauricular area. The staging 
examinations (PET/CT, peripheral blood investigations) were repeated and remained negative. In 
parallel to the superficial X-ray irradiation for the retroauricular lesions, treatment with low-dose 
methotrexate (15mg/week) was started in November 2011 and resulted in complete remission 
until last follow-up in January 2012. Several biopsies of the lesions on the right buttock, the 
lesions on the feet and the retroauricular papulo-nodular lesions were histologically examined.  
Case 2. An 87-year-old woman presented with a solitary, red infiltrated non-scaling plaque 
(diameter 5 cm) on the right lower leg (Figure 2). Her medical history was unremarkable for skin 
diseases or neoplastic diseases. The clinical examination did not reveal enlarged lymph nodes. 
The lesion was treated by radiation therapy (total dose 50 Gy). No recurrence was observed 
during follow-up of 2 years.  
Case 3. A 52-year-old man presented with a 1.3x0.8 cm solitary nodule on the right shoulder. 
The lesion was completely excised. The staging examinations did not reveal any extracutaneous 
involvement. One year later, on a regular check-up no evidence of cutaneous and extracutaneous 
disease. Blood examinations revealed a mild lymphocytosis, but no atypical lymphocytes. All 
findings were normal at the last follow up 26 months after diagnosis. 
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Histopathologic, immunophenotypic and molecular findings 
Common to all cases was a dense nodular to diffuse dermal infiltrate composed mainly of small 
and medium sized lymphocytes were found which were separated from the overlying epidermis 
by a variably thick Grenz zone (Figures 1C, 3A and 3B). The epidermis was either normal or 
focally atrophic with a loss of the undulated pattern. Specifically, no epidermotropism was 
observed in any of the biopsies of all three patients (Figure 3B). In all biopsies, the small to 
medium-sized lymphocytes showed chromatin dense nuclei with mild to moderate nuclear 
pleomorphism with cleaved nuclei (Figures 1D and 3C). A few eosinophilic granulocytes were 
admixed. In patient 1, several biopsies showed a granulomatous component with numerous 
histiocytes occasionally forming small epithelioid granulomas in addition to the lymphocytic 
infiltrate (Figure 1E). In addition, the lymphocytic infiltrates were centered on a slightly 
hyperplastic hair follicle but there was no folliculotropism in one of the biopsies of the acral 
lesions in patient 1 (Figure 1C).  
Immunohistochemically, the small to medium-sized lymphocytes were strongly positive for 
CD8, with about 80-90% of the cell population staining for this marker in each specimen 
(Figures 1F, 3D and 3E) (Table 1). A minority of the small lymphocytes (10-30% of the cells) 
expressed CD4 (Figures 1G and 3F). The cells expressed other T-cell markers (CD2, CD3 
[except for patient 3], CD5 and CD7) and were positive for betaF1 (Figure 3G). The CD8+ 
lymphocytes were negative for TIA-1, but granzyme B was expressed by 60-70% of the small to 
medium-sized lymphocytes in the biopsies of patient 1 and 2. In the biopsies of all patients, the 
lymphocytes were consistently negative for CD30 and CD56. There was an admixture of 
scattered medium-sized B-cells in the biopsy of patient 3. Less than 10 percent of the small to 
medium-sized CD8+ lymphocytes displayed proliferative activity in the Ki67/MIB-1 staining 
(Figure 1H). In the two patients (patients 1 and 3), from whom multiple biopsied were studied, 
the immunoprofile of the lymphoid cells was identical in each specimen. In situ hybridization 
performed in biopsies of patient 1 and 2 were negative. Due to lack of remaining tissue, this 
examination could not be performed in patient 3. 
Molecular biological T-cell clonality analyses revealed a clonal T-cell population in the biopsy 
of patient 2, whereas the infiltrates in the patient 1 and patient 3 were polyclonal.  
Discussion 
The common clinicopathological features to all our cases are papulo-nodular or plaque-like 
lesions without preceding patches and histologically nodular proliferations of small to medium 
sized CD8+ lymphocytes lacking epidermotropism. In the context of cutaneous lymphoid 
infiltrates, cases showing a cytotoxic phenotype should always alert the pathologist to a 
possibility of an aggressive cutaneous lymphoma but the lesions were report on are clearly 
different, both clinically and histopathologically, from aggressive cytotoxic lymphomas such as 
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primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma and other aggressive 
lymphoma type in which CD8 expression is commonly or occasionally observed such as 
subcutaneous panniculitis-like T-cell lymphoma, cutaneous gamma/delta T-cell lymphoma, and 
extranodal NK/T-cell lymphoma, nasal type. (13), (14), (15) CD8 phenotype has rarely been 
observed in less aggressive or rather indolent CTCL including mycosis fungoides, pagetoid 
reticulosis and CD30+ anaplastic large cell lymphoma. (16), (17), (18), (19) A cytotoxic 
infiltrate has recently been found in peculiar form of lupus erythematosus which showed an 
overlap of clinicopathological features with subcutaneous panniculitis-like T-cell lymphoma 
with overlapping clinicopathological features of lupus erythematosus. (20) All of the above 
diagnoses were clearly excluded in our patients. In particular, the lack of epidermotropism in all 
biopsies and the absence of preceding patches argue against CD8+ variant of MF as well as 
primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. Cutaneous gamma/delta 
lymphoma is excluded by the presence of beta F1 expression. The indolent clinical course and 
the lack of association with EBV exclude extranodal NK/T-cell lymphoma.  
 
Histopathologically, our cases are very similar to those reported as indolent CD8+ lymphoid 
proliferation of the ear (or face) but in all of our patients the lesions were located in extrafacial 
sites. So far, 5 patients (including our 3 patients) with CD8+ small/medium-sized lymphoid 
infiltrates at extrafacial sites have been reported (9), (10)  Their clinicopathologic features are 
summarized in Table 1. From the clinical aspect, the histological findings as well as the 
phenotype of the small to medium-sized lymphocytes, our cases are rare very similar or even 
identical to the patient reported by Khamaysi et al which was interpreted by the authors as CD8+ 
small to medium sized pleomorphic CTCL. (10) Classification of the CD8+ lymphoid infiltrates 
in our cases is challenging. Although the term cutaneous peripheral T-cell lymphoma, NOS 
(PTL, NOS) can be applied to cases which do not fit into any of the well-defined forms of CTCL 
and CD8 phenotype has indeed been observed in peripheral T-cell lymphoma, NOS, including 
cases with small to medium sized cytomorphology, such tumors usually run an aggressive 
clinical course. In a large study, cytotoxic phenotype has been found in about 15% of peripheral 
T-cell lymphoma, NOS, and a median survival of the affected patients was 28 months. (11) 
Clinically, our cases show a similar biological behavior as seen in CD4+ SMPTL which 
manifests in the vast majority of the patients with solitary or grouped plaques or nodules and run 
an indolent course with an excellent prognosis (11), (21)  Therefore our cases could be regarded 
as a phenotypic CD8+ lymphoproliferative analogue to the CD4+ SMPTL (Figure 4).  
 
In regard to the indolent course and the overlapping histological features, some authors indicated 
that CD4+ SMPTL cannot be distinguished with certainty form nodular pseudo-T-cell lymphoma 
and therefore proposed the term "cutaneous nodular proliferation of pleomorphic T-lymphocytes 
of undetermined significance (21), (22). In fact, some cases of pseudolymphoma composed of 
small and occasional medium sized cells may be overdiagnosed at present as small to medium 
sized pleomorphic T-cell lymphoma. (21), (23) Moreover, a CD8 phenotype has been reported in 
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rare cutaneous pseudolymphomas in HIV positive patients and other conditions characterized by 
lymphoid infiltrates, including lymphoid infiltration of Jessner-Kanof and palpable acriform 
migratory erythema (24), (25), (26) However, these lesions manifest a less prominent infiltrate 
composed almost exclusively of small cells. The possibility that the infiltrate in our patient 3 
represents a form of pseudolymphoma (reactive lymphoid hyperplasia) cannot be totally refuted, 
although no association with drug intake was reported by the patient. In addition, the lack of 
CD3 expression by the small to medium-sized tumor cells argues against pseudolymphoma.  
 
Patients with SMPTL appear to have a favorable prognosis independent of their CD4 or CD8 -
positive phenotype, especially those with a solitary lesion (10), (27), (9), (23)  Nevertheless, the 
relapsing course and the multifocal occurrence of tumoral lesions in patient 1 may indicate that 
the extrafacial CD8+ lymphoproliferations may in fact represent a prognostically heterogenous 
group as it has also been reported in CD4+ SMPTL. In the latter entity, cases with multiple 
rapidly growing tumors and a high proliferation rate may run a more aggressive course. (28) 
Thus a patient with multiple lesions should be followed more intensively and may require more 
intense treatment.  
 
An interesting feature observed in one case (Case 1) was the conspicuous granulomatous 
infiltration in the first biopsy. In the context of cutaneous lymphomas, granulomatous features 
are typically present in granulomatous slack skin and granulomatous mycosis fungoides and are 
rare in other lymphoma types. (29), (30), (31), (32) They have also been described in so-called 
pseudolymphomatous folliculitis, the term used to describe a distinctive pattern seen in both 
lymphomas and pseudolymphomas. (33), (34)  Along this line, some cases of 
“pseudolymphomatous folliculitis” and small to medium-sized pleomorphic CTCL show a great 
clinicopathological overlap. (34), (35), (36)  Whether in our patient the granulomatous (and 
lymphomatous) infiltrate who suffered from Bruton’s X-linked agammaglobulinemia may be 
related to immunoglobulin substitution or remains speculative. Similar histopathological findings 
have recently been reported in a Japanese patient afflicted X-linked agammaglobulinemia, 
including a heavy small to medium sized non-epidermotropic lymphoid infiltrate with cytotoxic 
CD8+ phenotype and a great admixture of histiocytes. (37)  The tumor was classified as 
peripheral CTCL, NOS and the patient clinically presented with multiple papules, macules and 
patches on the face and trunk. (37)  
 
In conclusion, we report a series of CD8+ small to medium-sized cell lymphoproliferations of 
the skin with an indolent behavior similar to those reported for CD8+ lymphoid proliferation on 
the ear and face, but all occurring in extrafacial sites. Further observations are needed collect a 
larger number of such cases in order to get insight into the biologic nature of the lesion 
(lymphoma or reactive process) and to find out whether they represent a prognostically 
heterogeneous group of lesions. If such lymphoproliferations would be classified as lymphoma, 
then according to the currently used schemes (WHO classification, 2008, 4th edition) they would 
8 
 
conform to the concept of cutaneous PTL, NOS and can perhaps be regarded as the CD8+ 
analogue of CD4+ SMPTL within a larger spectrum of nodular infiltrates of small to medium-
sized pleomorphic lymphocytes (Figure 4). A growing body of evidence suggests that what is 
nowadays called small to medium sized pleomorphic CTCL may in fact represent a 
phenotypically and prognostically heterogeneous group of lymphoproliferations. (28)  
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Figures 
 
Figure 1: Patient 1 - Clinicopathologic findings 
Fig. 1A: Scaly brownish plaque on the left foot at initial presentation. 
Fig. 1B: Relapse with erythematous papules adjacent to the site of previous radiation therapy.  
Fig. 1C: Superficial and deep nodular and confluent infiltrates. H&E, original magnification X20  
Fig. 1D: Small to medium-sized pleomorphic lymphocytes, H&E, original magnification X400 
Fig. 1E: Granulomatous component with sarcoid-like granulomas and numerous small to 
medium-sized lymphocytes with nuclear atypia. H&E, original magnification X200, 
Fig 1F: Expression of CD8 (red) by more than 80% of the small to medium-sized lymphocytes. 
Immunohistochemistry, original magnification X200. 
Fig 1G: Only small lymphocytes accounting for less than 20% of the infiltrate express CD4. 
(red). Immunohistochemistry, original magnification X200. 
Fig 1H: Proliferative activity of less than 10% of small to medium-sized pleomorphic 
lymphocytes.  
 
Figure 2: Patient 2 - Erythematous plaque on the right lower leg 
 
Figure 3: Patient 3 - Histological and phenotypic findings 
Fig 3A: Superficial and deep nodular infiltrates. H&E, original magnification X20 
Fig. 3B: Lymphocytic infiltrates separated from the overlying epidermis by an infiltrate-free 
Grenz zone. H&E, original magnification X200 
Fig. 3C: Small to medium-sized pleomorphic lymphocytes, H&E, original magnification X400 
Fig. 3D: Expression of CD8 (red) by nearly all lymphocytes. Immunohistochemistry, original 
magnification X100. 
Fig. 3E: Expression of CD8 (red) by more than 80% of the small to medium-sized pleomorphic 
lymphocytes. Immunohistochemistry, original magnification X200. 
Fig. 3F: Expression of CD4 (red) by less than 10% of the small to medium-sized pleomorphic 
lymphocytes. Immunohistochemistry, original magnification X200. 
Fig 3G: Less than 25% of the small to medium-sized pleomorphic lymphocytes express CD3 
(red). Immunohistochemistry, original magnification X200. 
 
Figure 4: Concept on the relationship between primary cutaneous small to medium-sized 
T-cell lymphoma with CD4+ or CD8+ expression, cutaneous CD8+ lymphoid 
proliferation of the ear / face and nodular pseudo-T-cell-lymphoma.  
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Table 1. The main clinicopathological features of cutaneous CD8+ small to medium sized 
lymphoid proliferations in extrafacial sites 
 
Case Sex/Age Location Clinical 
features 
Treatment 
Follow-up 
Histology IHC TCR 
Case 1 
 
M/48 Buttock 
(2007) 
Lower leg 
(2010) 
Multiple 
infiltrative 
papules and 
plaques 
Radiation 
therapy, 
 
Methotrexat 
(low-dose) 
 
Alive with 
disease (FU: 48 
months) 
Nodular 
infiltrate 
Small to 
medium sized 
cells; no 
epidermotropis
m 
Granulomatous 
reaction in one 
specimen 
CD2+, CD3+, 
CD4 (30%), 
CD5+,CD8 
(80%), CD30-, 
CD56-, 
granzyme 
(70%), 
perforin -TIA1 
(890%) 
Negative 
Case 2 
 
F/87 Lower leg Red 
infiltrated 
plaque 
Radiation therapy 
 
Complete  
remission 
(FU: 24 months) 
Diffuse infiltrate 
Small to 
medium sized 
cells; no 
epidermotropis
m 
CD2+, CD3+, 
CD4(30%), 
CD5+, CD7+ 
CD8 (80%), 
CD30-, CD56-
, granzyme B 
(60%), 
perforin -, 
TIA1 (70%)-  
Positive 
Case 3 
 
M/54 Shoulder 1.3x0.8 cm 
solitary 
nodule 
Surgical excision 
 
 
Complete 
remission (FU: 
28 months) 
Nodular 
infiltrate  
Small to 
medium sized 
cells; no 
epidermotropis
m 
CD3-,CD4 
10%), 
CD5+,CD8 
(90%), 
CD30-, CD56- 
Negative 
Case 
reported 
by  
Khamays
i et al 
2006 
F/55 Right foot Erythematou
s nodule 
(diameter 
2cm) 
Radiation therapy 
and surgical 
excision 
No FU available 
Lichenoid 
infiltrate 
Small to 
medium sized 
cells; no 
epidermotropis
m 
CD3+, CD8+  
CD4- CD20. 
CD30-, CD56- 
Positive 
Case 
reported 
by 
Friedman
n et al. 
1995 
F/57 Widesprea
d lesions 
Tumors and 
nodules 
Mechlorethamine
, radiation 
therapy, 
Psoralen-UVA 
(PUVA), 
Interferon-alpha 
(FU: no evidence 
of disease at 86 
months)  
Small to 
medium sized 
cells; no 
epidermotropis
m 
CD3+ ,CD8+ 
(50-75%) 
CD4 (<25%) 
CD5+, CD7- 
CD30- 
CD20 (<25%) 
 
Positive 
FU: Follow-up 
ND: not done 
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NR: not reported 
 
 
 
